To assess the potential prognostic implications of SLC20A1 expression in detail, we evaluated its association with tumor stage and endocrine therapy outcomes in patients with luminal A and luminal B breast cancers in the present study. The gene discussed is SLC20A1; the disease is breast carcinoma.